Dr. Atul Sherje

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents
  Biomedicine and Pharmacotherapy 2018 DOI: 10.1016/j.biopha.2018.04.021
  +Save
• Dendrimers: A versatile nanocarrier for drug delivery and targeting
  International Journal of Pharmaceutics 2018 DOI: 10.1016/j.ijpharm.2018.07.030
  +Save
• Development and Evaluation of pH-Responsive Cyclodextrin-Based in situ Gel of Paliperidone for Intranasal Delivery
  AAPS PharmSciTech 2018 DOI: 10.1208/s12249-017-0844-8
  +Save
• Host-guest interaction study of Efavirenz with hydroxypropyl‑β‑cyclodextrin and L‑arginine by computational simulation studies: Preparation and characterization of supramolecular complexes
  Journal of Molecular Liquids 2018 DOI: 10.1016/j.molliq.2018.02.131
  +Save
• Mycobacterial siderophore: A review on chemistry and biology of siderophore and its potential as a target for tuberculosis
  European Journal of Medicinal Chemistry 2018 DOI: 10.1016/j.ejmech.2018.08.030
  +Save
• Study on effect of L-arginine on solubility and dissolution of Zaltoprofen: Preparation and characterization of binary and ternary cyclodextrin inclusion complexes
  Chemical Physics Letters 2018 DOI: 10.1016/j.cplett.2018.01.025
  +Save
• Bone health and natural products-an insight
  Frontiers in Pharmacology 2018 DOI: 10.3389/fphar.2018.00981
  +Save
• Cyclodextrin-based nanosponges: A critical review
  Carbohydrate Polymers 2017 DOI: 10.1016/j.carbpol.2017.05.086
  +Save
• Inclusion Complexes of Nateglinide with HP–β–CD and L-Arginine for Solubility and Dissolution Enhancement: Preparation, Characterization, and Molecular Docking Study
  Journal of Pharmaceutical Innovation 2017 DOI: 10.1007/s12247-017-9275-z
  +Save
• Inclusion complexation of etodolac with hydroxypropyl-beta-cyclodextrin and auxiliary agents: Formulation characterization and molecular modeling studies
  Molecular Pharmaceutics 2017 DOI: 10.1021/acs.molpharmaceut.6b01115
  +Save